Possible scenario
Strong Research Uptake
38% Chance
The competition attracts leading academic labs, AI biology startups, and pharmaceutical research groups. The 150 million-cell atlas becomes a credible benchmark for target discovery, biomarker prediction, and patient-stratification models in early Alzheimer's disease.
Secondary impacts
- Healthcare +0.5%
- Technology +0.4%
Tickers
- RXRX+1.4%
- LLY+0.4%
Portfolio impact
S&P 500+0.2%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.